MedTrace Logo

Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"

NCT03284528 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-09-21

No results posted yet for this study

Summary

The histology of the placenta of newborn infants with perinatal asphyxia and hypoxic-ischaemic encephalopathy is analysed. There will be an evaluation if placenta could be a biomarker for neurodevelopmental outcome at 18-24 months of age.

Conditions

  • Asphyxia Neonatorum

Interventions

OTHER

hypothermia therapy

newborn infants with hypoxic-ischaemic encephalopathy are cooled for 72 hours with a target temperature of 33-34°C (whole body cooling).

Sponsors & Collaborators

  • University Children's Hospital, Zurich

    lead OTHER

Principal Investigators

  • Barbara Brotschi · University Childrens's hospital of Zurich

Eligibility

Min Age
1 Day
Max Age
4 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2017-01-01
Completion
2017-01-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284528 on ClinicalTrials.gov